India is a favorable sourcing destination for injectables and has many potential injectable CMOs with U.S. FDA/EU GMP-approved facilities capable of exporting to developed markets. A few big pharma companies have already partnered with Indian CMOs for their injectable requirements for the U.S., Europe, and other markets. Therefore, other pharma companies can capitalize on this and partner with Indian CMOs to export injectables to developed markets. Many countries are looking at reducing their healthcare expenditures
English
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)